Yüklüyor......
Have adjuvant tyrosine kinase inhibitors lost their shine?
Despite broad advances in molecularly targeted therapies, lung cancer remains the leading cause of cancer related mortality in the United States. Epidermal growth factor receptor (EGFR) mutations occur in approximately 17% of advanced non-small cell lung cancer (NSCLC) in the US population. The rema...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980379/ https://ncbi.nlm.nih.gov/pubmed/27568486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.07.18 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|